Triso
Automatic Anatomic Image Analysis and Evaluation
Startup Seed Health Tech & Life Sciences Est. 2016
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
3 rounds
Investors
1
1 public
Team
2
11-50 employees
Confidence
89/100
Patents
1
About
Triso is developing a platform for the automatic analysis and evaluation of anatomic images. The platform has a wide range of functionalities and can service a variety of medical disciplines. Its software is capable of accurately determining and precisely defining the boundaries of anatomic features from ultrasounds, CTs, and X-rays. Triso's patented imaging platform is developed in two modalities. The LV-Tricardio is a fully automated echocardiogram imaging platform, and the TriAngeo platform automatically traces the network arteries across an angiogram image, providing data on the entire arterial network.
Classification
Sector
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Core Technology
Simulation & Imaging
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
ct-scanultrasounddigital-healthcarex-rayimagingdiagnosticsradiologycardiologyhospitalshealthcare-providers
Funding & Events
Mar 2017
Non-equity Undisclosed
KamaTech
Jul 2020
Non-equity Undisclosed
Israel Innovation Authority
Jan 2018
Seed Undisclosed
Undisclosed Investor(s)
Details
Product Stage
Alpha
Employees
11-50
Exact Count
12
District
Jerusalem District
Founded
2016
Registrar
515287837
Locations
Bet Shemesh, Israel
Links
Website
LinkedIn
Careers
Admin
Last Update
Sep 21, 2024
Verified by
Yotam Maman
Missing
news, markets, not claimed
Team (2)
Michael Lyons
Co-founder & CEO
Founder
David Abergel
Co-founder & CTO
Founder